公司資料
Verve Therapeutics 股價、新聞與催化劑
- 股票代碼:
- VERV
- 交易所:
- NASDAQ
- 產業:
- Healthcare Services
- 所在地:
- United States
股價為何變動
目前無法取得 VERV 的收盤價變動背景。
公司概覽
業務概覽
Verve Therapeutics is a gene-editing and cardiovascular company focused on one-time treatments for atherosclerotic disease. It tries to bring the durability of genetic medicine into heart disease.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, Verve sits in advanced biotechnology.
商業模式特徵
The business is driven by platform validation, early clinical data, and the long-term opportunity to create a genetic cardiovascular franchise.
生技產業定位
Verve is one of the more interesting cardiovascular gene-editing names because it could redefine how heart disease is treated.
未來催化劑
- Verve Therapeutics's catalysts are its cardiovascular base-editing programs, especially the PCSK9 and LPA work, where the next human data decide whether in vivo editing is ready for prime time. The company needs a clean step forward to keep the gene-editing story credible.
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。